JP, K., JAE, K., NA, B., JM, H., J, J., S, K., . . . L, Z. (2023). Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy A position statement from the AEPC Working Group on Basic Science, Genetics and Myocardial Disease and the AEPC Working Group on Cardiac Dysrhythmias and Electrophysiology.
Citación estilo ChicagoJP, Kaski, et al. Indications and Management of Implantable Cardioverter-defibrillator Therapy in Childhood Hypertrophic Cardiomyopathy A Position Statement From the AEPC Working Group On Basic Science, Genetics and Myocardial Disease and the AEPC Working Group On Cardiac Dysrhythmias and Electrophysiology. 2023.
Cita MLAJP, Kaski, et al. Indications and Management of Implantable Cardioverter-defibrillator Therapy in Childhood Hypertrophic Cardiomyopathy A Position Statement From the AEPC Working Group On Basic Science, Genetics and Myocardial Disease and the AEPC Working Group On Cardiac Dysrhythmias and Electrophysiology. 2023.